 - Patients with histologically diagnosed relapsed high grade serous ovarian cancer including primary peritoneal andor fallopian tube cancer or high grade endometrioid cancer. Patients are eligible to undergo BRCA testing even if they have not yet had recurrence or progression of disease 6 months 183 days after completion of their last platinum therapy. 